Insud Pharma has completed the transaction to acquire the women’s healthcare business, primarily related to oral and injectable contraceptives, from Viatris. The transaction was first announced in ...
PRINCETON, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. ("Agile") (OTCQB: AGRX), a women's healthcare company, today announced that it has entered into a definitive merger ...
PRINCETON, N.J., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. ("Agile") (OTCQB: AGRX), a women's healthcare company, today announced the completion of the acquisition of Agile by Insud ...
Insud Pharma, a leading Spanish company with a track record in the pharmaceutical and healthcare industry, announced that it has entered into an agreement with Fresenius Kabi. Under the terms of the ...
Exeltis will be granted an exclusive license to market and distribute Theranexus' novel formulation TX01 for the treatment of two rare neurological diseases notably in Europe. Theranexus will be ...
FRANKFURT (Reuters) - Spain's Insud Pharma plans to sell a stake in its biopharmaceuticals unit mAbxience in a deal that is expected to value the maker of monoclonal antibodies at about 1 billion ...
Agile Therapeutics will combine with Insud Pharma’s US Subsidiary, Exeltis, expanding an already significant Women’s Health/contraceptive portfolio Agile Therapeutics Common Shareholders expected to ...
This agreement will bring new business to the biotech company, which is expanding its manufacturing capabilities and maintains its identity, brand, and complete team The transaction validates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results